Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,987
Closed -$4.83M 56
2024
Q3
$4.83M Sell
14,987
-6,843
-31% -$2.24M 1.58% 31
2024
Q2
$6.82M Sell
21,830
-404
-2% -$119K 2.32% 14
2024
Q1
$6.32M Buy
22,234
+82
+0.4% +$24K 2.29% 15
2023
Q4
$6.38M Buy
22,152
+8,581
+63% +$2.34M 2.42% 12
2023
Q3
$3.65M Buy
+13,571
New +$3.39M 1.7% 27
2022
Q3
Sell
-45
Closed -$11K 52
2022
Q2
$11K Buy
+45
New +$11K 0.01% 96

Other funds holding AMGN

Legacy CG's AMGN Position: Q4 2024 in Review

Legacy CG sold out of Amgen (AMGN) in Q4 2024, closing a stake of 14,987 shares — an estimated $4.83M sold.

Legacy CG first reported a position in AMGN in Q2 2022 and held it in 6 quarters. The position peaked at $6.82M in Q2 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Legacy CG reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Legacy CG sold 14,987 Amgen shares in Q4 2024, an estimated $4.83M.
  • Legacy CG first reported a position in Amgen in Q2 2022 and held it in 6 quarters.
  • Legacy CG's Amgen position peaked at $6.82M in Q2 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Legacy CG's 13F filing for Q4 2024, filed 27 Jan 2025.